Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.57 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.54 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.52 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31679316 | 0.90 | OPRM1 (0.53) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL31362630 | 0.90 | OPRM1 (0.65) | F2OPRD1OPRM1SLC6A2 | |
| SCHEMBL30423592 | 0.89 | F2 (0.59) | F2OPRD1OPRM1SLC6A2NMUR2 | |
| SCHEMBL31679365 | 0.89 | OPRM1 (0.51) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL31473044 | 0.88 | NMUR2 (0.58) | OPRD1OPRM1NMUR2NMUR1 | |
| SCHEMBL31679485 | 0.88 | OPRM1 (0.49) | OPRD1OPRM1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL30423827 | 0.88 | NMUR2 (0.57) | F2OPRD1OPRM1NPFFR1NPFFR2 | |
| SCHEMBL31679323 | 0.88 | OPRM1 (0.56) | F2OPRD1OPRM1NPFFR1NPFFR2 | |
| SCHEMBL29973454 | 0.87 | NMUR2 (0.57) | F2OPRD1OPRM1NPFFR1NPFFR2 | |
| SCHEMBL31692757 | 0.87 | NTSR2 (0.53) | F2OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | claimed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |